Analysis

Purdue Opts Into New Release Reality To Win Ch. 11 Plan OK

By Vince Sullivan · November 18, 2025, 8:21 PM EST

Shifting to an opt-in release mechanism in response to a U.S. Supreme Court ruling got Purdue's revamped Chapter 11 plan to confirmation by giving claimants the choice to pursue members of...

To view the full article, register now.

Bankruptcy Scorecard

Summary

Purdue Pharma filed for bankruptcy after reaching a settlement deal to end over 2,600 lawsuits that accused the maker of OxyContin of fueling a national opioid addiction crisis. In June 2024, the U.S. Supreme Court overturned Purdue's Chapter 11 plan finding non-debtor third parties, like Purdue's former owners the Sackler family, aren't authorized to receive non-consensual liability waivers under the U.S. Bankruptcy Code.

Case Number

19-bk-23649

Judge

Sean H. Lane

Venue

U.S. Bankruptcy Court for the Southern District of New York

Capital Structure

View Full Scorecard